Item 7A. Quantitative and Qualitative Disclosures About Market Risk
ITEM
7A. QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK
General
We
are required to make certain disclosures regarding our financial instruments, including derivatives, if any.
A
financial instrument is defined as cash, evidence of an ownership interest in an entity, or a contract that imposes on one entity
a contractual obligation either to deliver or receive cash or another financial instrument to or from a second entity. Examples
of financial instruments include cash and cash equivalents, deposits, trade accounts receivable, loans, investments, trade accounts
payable, accrued expenses, options and forward contracts. The disclosures below include, among other matters, the nature and terms
of derivative transactions, information about significant concentrations of credit risk, and the fair value of financial assets
and liabilities.
Fair
Value of Financial Instruments
Fair
values of financial instruments included in current assets and current liabilities are estimated to approximate their book values
due to the short maturity of such investments.
Concentrations
of Credit Risk
The
Company’s financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally
of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to approximately $2,063,000
at December 31, 2020. Approximately 32% of the accounts receivable at December 31, 2020 was due from two customers, 20% from one
and 12% from another, who pay their receivables over usual credit periods. Credit risk with respect to the balance of trade receivables
is generally diversified due to the number of entities comprising the Company’s customer base. The Company does not believe
there is significant risk of non-performance by these counterparties.
Interest
Rate Risk
In
March 2019, OmniMetrix reinstated its loan and security agreement which provided OmniMetrix with access to accounts receivable
formula-based financing of the lesser of 75% of eligible receivables or $1 million. Debt incurred under this financing arrangement
bore interest at the greater of 6% and prime plus 1.5% per year. In addition, OmniMetrix paid a monthly service charge of 0.75%
of the average aggregate principal amount outstanding for the prior month, for an effective rate of interest on advances of 15%.
OmniMetrix also agreed to maintain a minimum loan balance of $150,000 in its line-of-credit with the lender for a minimum of two
years beginning March 1, 2019. From time to time, the balance outstanding fell below $150,000 based on collections applied against
the loan balance and the timing of loan draws. We elected not to renew this line of credit and allowed it to expire in accordance
with its terms on February 28, 2021. OmniMetrix no longer has interest rate risk related to debt.
24
COVID-19
Pandemic Risk to Supply Chain
As
discussed above under the “RISK FACTORS” heading, the COVID-19 pandemic could substantially interfere with general
commercial activity related to our supply chain and customer base, which could have a material adverse effect on our financial
condition, results of operations, business, or prospects. Some of the electronic devices and hardware we purchase, like antennas,
radios, and GPS modules are very specific to our application; there are not likely to be practical alternatives. In some cases,
our circuit boards were designed around specific electronic hardware that met our specifications. We continue to work closely
with our contract manufacturers and suppliers in order to mitigate as much as possible the risks to our supply chain for these
critical devices and hardware, including identifying any lead-time issues and any potential alternate sources. We also continue
to examine all currently open purchase orders in an effort to identify whether we need to issue additional orders to secure product
that is critical, already has questionable lead times and/or is unique to our requirements. Alternate sources may not be available
or may result in delays in shipments to us from our supply chain and subsequently to our customers, each of which would affect
our results of operations. Further, if our customers’ businesses are similarly affected as a result of the pandemic, they
might delay or reduce purchases from us, which could adversely affect our results of operations.
ITEM
8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA
Furnished
at the end of this report commencing on page F-1.
ITEM
9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE
None.
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.